Correlation Between PYC Therapeutics and Macquarie

Can any of the company-specific risk be diversified away by investing in both PYC Therapeutics and Macquarie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PYC Therapeutics and Macquarie into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PYC Therapeutics and Macquarie Group, you can compare the effects of market volatilities on PYC Therapeutics and Macquarie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PYC Therapeutics with a short position of Macquarie. Check out your portfolio center. Please also check ongoing floating volatility patterns of PYC Therapeutics and Macquarie.

Diversification Opportunities for PYC Therapeutics and Macquarie

0.37

Correlation Coefficient

PYC Therapeutics  Macquarie

Weak diversification

The 3 months correlation between PYC and Macquarie is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding PYC Therapeutics and Macquarie Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Macquarie Group and PYC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PYC Therapeutics are associated (or correlated) with Macquarie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Macquarie Group has no effect on the direction of PYC Therapeutics i.e., PYC Therapeutics and Macquarie go up and down completely randomly.

Pair Corralation between PYC Therapeutics and Macquarie

Assuming the 90 days trading horizon PYC Therapeutics is expected to under-perform the Macquarie. In addition to that, PYC Therapeutics is 4.28 times more volatile than Macquarie Group. It trades about -0.29 of its total potential returns per unit of risk. Macquarie Group is currently generating about -0.18 per unit of volatility. If you would invest  23,244  in Macquarie Group on September 27, 2024 and sell it today you would lose (931.00) from holding Macquarie Group or give up 4.01% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

PYC Therapeutics  vs.  Macquarie Group

PYC Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Macquarie Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Macquarie Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Macquarie is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with PYC Therapeutics and Macquarie

The main advantage of trading using opposite PYC Therapeutics and Macquarie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PYC Therapeutics position performs unexpectedly, Macquarie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Macquarie will offset losses from the drop in Macquarie's long position.

The idea behind PYC Therapeutics and Macquarie Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.